You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 137 No. 6, June 2001 TABLE OF CONTENTS
  Archives
  •  Online Features
  Observation
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on ISI (10)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Genetics
 •Genetic Disorders
 •Pediatrics
 •Bullous Diseases
 •Neonatology and Infant Care
 •Alert me on articles by topic

Vesiculopustular Eruptions in Down Syndrome Neonates With Myeloproliferative Disorders

Anita Nijhawan, MD; Eulalia Baselga, MD; M. Antonia Gonzalez-Ensenat, MD; A. Vicente, MD; James F. Southern, MD; Bruce M. Camitta, MD; Nancy B. Esterly, MD; Beth A. Drolet, MD

Arch Dermatol. 2001;137:760-763.

Background  Infants with Down syndrome are at increased risk for hematologic abnormalities, including leukemoid reaction, transient myeloproliferative disorder, and congenital leukemia. The differential diagnosis of a vesiculopustular eruption in an infant with Down syndrome and these hematologic abnormalities is broad and includes benign, self-limited disorders as well as life-threatening infections.

Observation  We describe 3 newborns with Down syndrome and vesiculopustular eruptions associated with myeloproliferative disorders during the neonatal period. These lesions differ from other neonatal vesicular eruptions in that they have a unique distribution, display pathergy, and contain immature hematopoietic cells similar to circulating blast cells. Resolution occurs without treatment as the hematologic disorder subsides.

Conclusions  Infants with Down syndrome and hematologic abnormalities may have a cutaneous eruption that has characteristic clinical and histopathologic findings. It is possible that this eruption has been unrecognized in the past because of its self-limited course. Whether this eruption is a prognostic factor for the subsequent development of leukemia is uncertain.


From the Departments of Dermatology (Drs Nijhawan, Esterly, and Drolet), Pathology (Dr Southern), Pediatrics (Drs Camitta, Esterly, and Drolet), and Hematology (Dr Camitta), Medical College of Wisconsin, Milwaukee; and Department of Dermatology, Institut Universitari Dexeus (Dr Baselga), and Hospital de Sant Joan de Deu (Drs Gonzalez-Ensenat and Vicente), Barcelona, Spain.


RELATED ARTICLE

Archives of Dermatology Reader's Choice: Continuing Medical Education
Arch Dermatol. 2001;137(6):841-842.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Case 19-2003 - A Five-Day-Old Girl with Leukocytosis and a Worsening Rash from Birth
Wolfe et al.
NEJM 2003;348:2557-2566.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.